These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11106248)
1. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Seike M; Gemma A; Hosoya Y; Hemmi S; Taniguchi Y; Fukuda Y; Yamanaka N; Kudoh S Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248 [TBL] [Abstract][Full Text] [Related]
2. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400 [TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839 [TBL] [Abstract][Full Text] [Related]
4. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Okamoto A; Hussain SP; Hagiwara K; Spillare EA; Rusin MR; Demetrick DJ; Serrano M; Hannon GJ; Shiseki M; Zariwala M Cancer Res; 1995 Apr; 55(7):1448-51. PubMed ID: 7882351 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333 [TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Kim DH; Nelson HH; Wiencke JK; Christiani DC; Wain JC; Mark EJ; Kelsey KT Oncogene; 2001 Mar; 20(14):1765-70. PubMed ID: 11313923 [TBL] [Abstract][Full Text] [Related]
8. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
9. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302 [TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas. Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines. Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486 [TBL] [Abstract][Full Text] [Related]
12. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. Wolf P; Hu YC; Doffek K; Sidransky D; Ahrendt SA Cancer Res; 2001 Nov; 61(22):8113-7. PubMed ID: 11719438 [TBL] [Abstract][Full Text] [Related]
13. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient. Glendening JM; Flores JF; Walker GJ; Stone S; Albino AP; Fountain JW Cancer Res; 1995 Dec; 55(23):5531-5. PubMed ID: 7585628 [TBL] [Abstract][Full Text] [Related]
14. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors. Knapek DF; Serrano M; Beach D; Trono D; Walker CL Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460 [TBL] [Abstract][Full Text] [Related]
15. [p16INK4/CDKN2 gene deletions and mutations in non-small cell lung cancers]. Wang G; Du C; Lin Q Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):5-8. PubMed ID: 9456359 [TBL] [Abstract][Full Text] [Related]
16. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Esteller M; Sanchez-Cespedes M; Rosell R; Sidransky D; Baylin SB; Herman JG Cancer Res; 1999 Jan; 59(1):67-70. PubMed ID: 9892187 [TBL] [Abstract][Full Text] [Related]
17. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance. Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800 [TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
19. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. Wong IH; Ng MH; Lee JC; Lo KW; Chung YF; Huang DP Br J Haematol; 1998 Oct; 103(1):168-75. PubMed ID: 9792305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]